ID
14580
Beschrijving
Real-Life Evidence on Stroke Prevention in SPAF; ODM derived from: https://clinicaltrials.gov/show/NCT02485873
Link
https://clinicaltrials.gov/show/NCT02485873
Trefwoorden
Versies (1)
- 22-04-16 22-04-16 -
Geüploaded op
22 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873
Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Atrial Fibrillation | Heart Valves
Datatype
boolean
Alias
- UMLS CUI [1]
- C0004238
- UMLS CUI [2]
- C0018826
Beschrijving
oral anticoagulants | Vitamin K antagonists | dabigatran | rivaroxaban
Datatype
boolean
Alias
- UMLS CUI [1]
- C0354604
- UMLS CUI [2]
- C3653316
- UMLS CUI [3]
- C2348066
- UMLS CUI [4]
- C1739768
Beschrijving
Other oral anticoagulants
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0354604
Beschrijving
rivaroxaban | cohort
Datatype
boolean
Alias
- UMLS CUI [1]
- C1739768
- UMLS CUI [2]
- C0599755
Similar models
Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873
- StudyEvent: Eligibility
C0018826 (UMLS CUI [2])
C1522577 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
C0451369 (UMLS CUI [1,2])
C0018826 (UMLS CUI [2])
C3653316 (UMLS CUI [2])
C2348066 (UMLS CUI [3])
C1739768 (UMLS CUI [4])
C0354604 (UMLS CUI [1,2])
C0599755 (UMLS CUI [2])